Assuntos
Betacoronavirus , Infecções por Coronavirus , Disseminação de Informação , Pneumonia Viral , Pesquisa Biomédica , COVID-19 , China , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/transmissão , Pessoal de Saúde , Humanos , Relações Interprofissionais , Pneumonia Viral/epidemiologia , Pneumonia Viral/prevenção & controle , Pneumonia Viral/transmissão , Saúde Pública , SARS-CoV-2 , Ciência , Revelação da VerdadeAssuntos
Doenças Transmissíveis Emergentes/prevenção & controle , Doenças Transmissíveis Emergentes/virologia , Surtos de Doenças/prevenção & controle , Pandemias/prevenção & controle , Viroses/prevenção & controle , Viroses/virologia , Vírus/isolamento & purificação , Animais , Pesquisa Biomédica/economia , Quirópteros/virologia , Doenças Transmissíveis Emergentes/epidemiologia , Interações Hospedeiro-Patógeno , Humanos , Projetos Piloto , Viroses/epidemiologia , Vírus/genética , Zoonoses/transmissão , Zoonoses/virologiaRESUMO
Tiffany Bogich and colleagues find that breakdown or absence of public health infrastructure is most often the driver in pandemic outbreaks, whose prevention requires mainstream development funding rather than emergency funding.
Assuntos
Fortalecimento Institucional/métodos , Pandemias/prevenção & controle , Administração em Saúde Pública , Teoria de Sistemas , Fortalecimento Institucional/economia , Saúde Global , Órgãos Governamentais , Humanos , Agências Internacionais , Cooperação Internacional , Organizações sem Fins Lucrativos , Administração em Saúde Pública/economiaRESUMO
Most pandemics--eg, HIV/AIDS, severe acute respiratory syndrome, pandemic influenza--originate in animals, are caused by viruses, and are driven to emerge by ecological, behavioural, or socioeconomic changes. Despite their substantial effects on global public health and growing understanding of the process by which they emerge, no pandemic has been predicted before infecting human beings. We review what is known about the pathogens that emerge, the hosts that they originate in, and the factors that drive their emergence. We discuss challenges to their control and new efforts to predict pandemics, target surveillance to the most crucial interfaces, and identify prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can identify and report hitherto unknown microbes in other species, and thus new risk assessment approaches are needed to identify microbes most likely to cause human disease. We lay out a series of research and surveillance opportunities and goals that could help to overcome these challenges and move the global pandemic strategy from response to pre-emption.
Assuntos
Pandemias/prevenção & controle , Zoonoses/epidemiologia , Animais , Patógenos Transmitidos pelo Sangue , Doenças Transmissíveis Emergentes/epidemiologia , Doenças Transmissíveis Emergentes/prevenção & controle , Monitoramento Ambiental , Saúde Global , Política de Saúde , Humanos , Cooperação Internacional , Viagem , Viroses/epidemiologia , Viroses/prevenção & controleRESUMO
Global cooperation is essential for coordinated planning and response to public health emergencies, as well as for building sufficient capacity around the world to detect, assess and respond to health events. The United States is committed to, and actively engaged in, supporting disease surveillance capacity building around the world. We recognize that there are many agencies involved in this effort, which can become confusing to partner countries and other public health entities. This paper aims to describe the agencies and offices working directly on global disease surveillance capacity building in order to clarify the United States Government interagency efforts in this space.